Bisphosphonates: ready for use as adjuvant therapy of breast cancer?

Current opinion in obstetrics & gynecology

Volumn 22, Issue 1, 2010, Pages 61-66

  Theriault, Richard L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE;

ADJUVANT CHEMOTHERAPY; BONE TUMOR; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; METABOLIC BONE DISEASE; METASTASIS; REVIEW;

ANTINEOPLASTIC AGENTS; BONE DISEASES, METABOLIC; BONE NEOPLASMS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DIPHOSPHONATES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS;

MLCS; MLOWN;

EID: 77951210795     PISSN: None     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/gco.0b013e328334e43b     Document Type: Review

References (45)